C
Cipher Pharmaceuticals (TSX: CPH) (OTCQX:CPHRF) is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets these products directly in Canada or indirectly through partners in the U.S., Canada and South America.
Investor insights
Funding rounds participated in
$35M sweet spot round size
Investor type
Public Company
Basic info
Industry
Pharmaceutical Manufacturing
Sectors
Pharmaceutical Manufacturing
Date founded
2000
Funding rounds raised
Total raised
$35M
from 1 investors over 1 rounds
C
Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX:CPHRF) raised $35M on April 1, 2023
Investors: Royal Bank of Canada